quinazolines has been researched along with iridoids in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dalcol, II; Graebner, IB; Morel, AF; Porto, C | 1 |
| Elgindy, NA; Elzoghby, AO; Samy, WM | 1 |
| Hua, J; Sun, Y; Yuan, Y; Zhang, L; Zhang, Z | 1 |
3 other study(ies) available for quinazolines and iridoids
| Article | Year |
|---|---|
Study on the antimicrobial activity of Hymatanthus sucuba.
Topics: Alkaloids; Anti-Infective Agents; Apocynaceae; Bacillus subtilis; Candida; Escherichia coli; Iridoids; Klebsiella pneumoniae; Lactones; Microbial Sensitivity Tests; Plant Extracts; Plant Leaves; Plant Roots; Plants, Medicinal; Pseudomonas aeruginosa; Quinazolines; Saccharomyces cerevisiae; Salmonella; Staphylococcus | 2006 |
Novel spray-dried genipin-crosslinked casein nanoparticles for prolonged release of alfuzosin hydrochloride.
Topics: Adrenergic alpha-1 Receptor Antagonists; Caseins; Cross-Linking Reagents; Delayed-Action Preparations; Desiccation; Iridoids; Nanoparticles; Quinazolines | 2013 |
UCP-2 inhibitor enhanced the efficacy of trastuzumab against HER2 positive breast cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; Iridoids; Neoadjuvant Therapy; Oxazoles; Pyridines; Quinazolines; Receptor, ErbB-2; Trastuzumab; Uncoupling Protein 2 | 2021 |